HLVX Insider Trading

Insider Ownership Percentage: 71.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $193,765.70

HilleVax Insider Trading History Chart

This chart shows the insider buying and selling history at HilleVax by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500M$0$500MTotal Insider BuyingTotal Insider Selling

HilleVax Share Price & Price History

Current Price: $1.42
Price Change: Price Decrease of -0.03 (-2.07%)
As of 04/4/2025 05:00 PM ET

This chart shows the closing price history over time for HLVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$1.42Closing price on 04/05/25:

SEC Filings (Institutional Ownership Changes) for HilleVax (NASDAQ:HLVX)

86.42% of HilleVax stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HLVX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$14Mbought$1.06MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M$0$10MTotal InflowsTotal Outflows
HilleVax logo
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Read More on HilleVax

Today's Range

Now: $1.42
Low: $1.34
High: $1.50

50 Day Range

MA: $1.77
Low: $1.39
High: $1.99

52 Week Range

Now: $1.42
Low: $1.34
High: $16.31

Volume

665,777 shs

Average Volume

434,993 shs

Market Capitalization

$71.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.86

Who are the company insiders with the largest holdings of HilleVax?

HilleVax's top insider shareholders include:
  1. Life Sciences X LP Frazier (Major Shareholder)
  2. Robert Hershberg (Insider)
  3. Aditya Kohli (Director)
  4. Astrid Borkowski (Insider)
  5. Shane Maltbie (CFO)
  6. Sean Mcloughlin (COO)
Learn More about top insider investors at HilleVax.